Two potential mechanisms of oxaliplatin-induced haemolytic anaemia in a single patient.
Only two patients with adequately documented oxaliplatin-induced autoimmune haemolytic anaemia have previously been reported. We report here a third patient with an immune-haematological finding favouring a bispecific mechanism (immune-complex and penicillin type) of oxaliplatin-induced haemolysis.
Hofheinz
Ralf-Dieter
RD
III. Medical Clinic, University Hospital Mannheim, University of Heidelberg, Wiesbadener Strasse 7-11, 68167 Mannheim, Germany. ralf.hofheinz@med3.ma.uni-heidelberg.de
Nguyen
Xuan-Duc
XD
Buchheidt
Dieter
D
Kerowgan
Mohammed
M
Hehlmann
Rüdiger
R
Hochhaus
Andreas
A
D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001327:Autoimmune Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000276:immunology; D005260:Female; D006801:Humans; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D000077150:Oxaliplatin
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin